Study design and study population
stroke
STROKE, SECONDARY, RECURRENCE
The study was conducted as a subanalysis from a randomized controlled trial at Sorlandet Hospital Arendal, Norway in the period 2007–2022. The main study focused on differences between secondary cardiovascular prevention within primary health care and within hospital-based follow-up, and primary outcomes were all-cause mortality and composite endpoint of all-cause mortality, recurrence of non-fatal MI, new PCI/CABG, and non-fatal stroke.Consecutive women and men, aged 18 to 80 years, admitted to the hospital with a diagnosis of MI or after scheduled PCI/CABG were randomized to hospital-based follow-up or to follow-up within the primary health care [